RARE MANIFESTATION OF ANTI-NMDAR ENCEPHALITIS
Keywords:N-methyl-D-aspartate receptor (NMDAR) encephalitis, neuronal plasticity, chorea, rheumatic fever
AbstractN-methyl-d-aspartate receptor (NMDAR) antibody encephalitis is an autoimmune syndrome with the development of antibody production against the NMDAR, affecting synaptic plasticity and cognition. It has a common association with ovarian teratomas with women being affected disproportionately. We present a case of an eight-year-old female child presented with complaints of fever, altered level of consciousness and choreiform movements. Owing to its common occurrence in the developing world, initially, rheumatic fever was kept in the differential diagnosis and was treated accordingly, but through a series of investigations, was diagnosed as a case of N-methyl-d-aspartate receptor (NMDAR) antibody encephalitis. This case report urges the healthcare providers to keep Anti NMDAR encephalitis as a differential in their minds, while dealing with patients, having chorea as their main clinical manifestation. Owing to its rarity, we have primarily reported it here.
Maggio MC, Mastrangelo G, Skabar A, Ventura A, Carrozzi M, Santangelo G, et al. Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: two case reports. J Med Case Rep 2017;11(1):225.
Osei‐Lah A, Durrant E, Hussain M, Kirkham F. Focal EEG slowing and chorea: electroclinical clues to the diagnosis of anti‐NMDAR Encephalitis. Epileptic Disord 2014;16(4):482–5.
Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012;54(7):899–904.
Samanta D, Lui F. Anti-NMDA Receptor Encephalitis. [Updated 2021 Jul 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. [cited 2021 Aug]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551672/
Udani V, Desai N, Botre A. Partial Manifestation of Anti‐NMDA‐R Encephalitis with Predominant Movement Disorder. Mov Disord Clin Pract 2016;3(1):80–2.
Singer HS. Autoantibody-associated movement disorders in children proven and proposed. Semin Pediatr Neurol 2017;24(3):168–79.
Rheumatic Fever: Background, Pathophysiology, Epidemiology. [Internet]. [cited 2020 Dec 15]. Available from: https://emedicine.medscape.com/article/236582-overview#a6
Tu NP, Nha PB, Hung ND, Minh NH, Anh HN, Dinh TC. Treatment of Anti–NMDA Receptor Encephalitis with Ovarian Teratoma Removal: A Literature Review and Two Case Reports. Open Access Maced J Med Sci 2019;7(24):4378–82.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.